Our Stocks to Watch include Opexa Therapeutics Inc. (Nasdaq: OPXA), Alloy Steel International Inc. (OTCBB: AYSI), PHI Mining Group Inc. (OTC: PHIG), Adeona Pharmaceuticals Inc. (AMEX: AEN), The Football Network Inc. (OTC: TFNK) and SoftNet Technology Corp. (OTCBB: SOFN).
Visit http://www.otcpicks.com/microcap.htm today to join this growing community.
OPEXA THERAPEUTICS INCORPORATED (NASDAQ: OPXA)
"Up 269.93% on Tuesday"
Detailed Quote: http://www.otcpicks.com/quotes/OPXA.php
Opexa Therapeutics, Inc. is dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases. The Company’s leading therapy, Tovaxin, is an individualized cellular immunotherapy treatment in Phase IIb clinical development for Multiple Sclerosis (MS). Tovaxin is derived from T-cells isolated from peripheral blood, expanded ex vivo, and reintroduced into the patients via subcutaneous injections. This process triggers a potent immune response against specific subsets of autoreactive T-cells known to attack myelin and, thereby, reduces the risk of relapse over time. Data from the first Phase IIb clinical study showed compelling evidence that Relapsing Remitting MS patients treated with Tovaxin saw overall clinical, MRI, and immunological benefits over the placebo group, including statistical significance for decrease in the Annualized Relapse Rate (ARR), improvement in disability score (EDSS), and improvement in quality of life measures (MSQLI), as well as an excellent safety profile with no serious adverse events related to Tovaxin treatment.
OPXA News:
September 8 - Opexa to Present at the Rodman & Renshaw 11th Annual Healthcare Conference September 11, 2009
Opexa Therapeutics, Inc. (Nasdaq: OPXA), a company developing Tovaxin®, a personalized T-cell immunotherapy for multiple sclerosis (MS), announced that Neil K. Warma, Opexa’s president and chief executive officer, will deliver a corporate presentation at Rodman & Renshaw’s 11th Annual Healthcare Conference. The conference will be held September 9-11, 2009, at the Palace Hotel in
Opexa’s presentation will take place at 10:50 a.m. (EST) on Friday, September 11, 2009 in the Henry Salon (5th floor) of the NY Palace Hotel. The presentation will include an overview of the company’s ongoing development program for Tovaxin, the company’s lead therapy for MS and an overview of the recently announced stem cell agreement with Novartis.
ALLOY STEEL INTERNATIONAL INCORPORATED (OTCBB: AYSI)
"Up 154.55% on Tuesday"
Detailed Quote: http://www.otcpicks.com/quotes/AYSI.php
Alloy Steel International, Inc., together with its subsidiary, Alloy Steel Australia (Int.) Pty Ltd., engages in the manufacture and distribution of Arcoplate, a wear-resistant alloy overlay wear plate. It offers fused-alloy steel plates for installation and use in structures and machinery that suffer wear and hang-up problems. The company is also developing the 3-D Pipefitting Cladder process. Alloy Steel International's customer base primarily consists of companies involved in the mining and dredging industries in
AYSI News:
September 8 - Alloy Steel International Signs Supply Agreement With BHP Billiton
Mr. Gene Kostecki, Chairman and CEO of Alloy Steel International (OTCBB: AYSI), announced that Alloy Steel Australia (Int) Pty Ltd a wholly owned subsidiary of Alloy Steel International Inc. has signed a long term strategic supply agreement with BHP Billiton to supply Arcoplate Wear Resistant Super Alloy Wearplate for iron ore mining operations in Western Australia.
The initial product taken will be for the multi-million dollar expansion of their operations in the Pilbara area of
Since the announcement in August 2009 of Alloy Steel's successful commissioning, the increased level of interest in the new production mill shown in Arcoplate has been outstanding, according to Mr. Kostecki. Most of the major iron ore miners in
Since commissioning the new Arcoplate mill, it has been working at full capacity satisfying the demand for the new 3/4 inch or 20mm material whilst the other Arcoplate mill has been fully utilized with the ongoing demand for the thinner overlay materials.
As a result of the increased level of interest in Alloy Steel's Arcoplate product by local and international mining companies, the Directors of Alloy Steel are planning for a further two production mills with substantially increased capacity to come on line in early 2010.
PHI MINING GROUP INCORPORATED (OTC: PHIG)
"Up 142.42% on Tuesday"
Detailed Quote: http://www.otcpicks.com/quotes/PHIG.php
PHI Mining Group is a U.S.-based mining and exploration enterprise focused on acquiring and developing precious metal, base metal and industrial mineral properties. The company has signed agreements to acquire interests in gold, lead, zinc, copper, granite, and limestone properties in
PHIG News:
September 8 - PHI Mining Group's Subsidiary Receives Thai Granite and Marble Mining License
PHI Mining Group, Inc. (OTC: PHIG) (Frankfurt Stock Exchange: RPBA), a company engaged in mining, announced that its subsidiary IMC Granite Marble Thailand Company, Ltd. has been granted Mining License # 1/2552 for granite and marble mining by the Department of Primary Industries and Mines, Nakorn Ratchasima Province, Thailand.
The black pearl granite and marble mining area in connection with this license is situated in
The granting of this license is a result of the joint venture agreement between Indochina Mining Corporation (IMC), a wholly-owned subsidiary of PHI Mining Group, and Mr. Chinnawat Chaikijjanuwat of
As references for the potential value of the above-mentioned mines, recent market prices for black pearl granite, brown marble, black marble, and yellow marble FOB
ADEONA PHARMACEUTALS INCORPORATED (AMEX: AEN)
"Up 85.71% on Tuesday"
Detailed Quote: http://www.otcpicks.com/quotes/AEN.php
Adeona Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to the awareness, prevention and treatment of subclinical zinc deficiency and chronic copper toxicity in the mature population. Adeona believes that such conditions may contribute to the progression of debilitating degenerative diseases, including, dry age-related macular degeneration (dry AMD), Alzheimer's disease (AD) and mild cognitive impairment (MCI) in susceptible persons. Adeona is also developing a number of late-stage clinical drug candidates for the treatment of rheumatoid arthritis and multiple sclerosis.
AEN News:
September 8 - Adeona Forms Initial Sales and Marketing Team for Its Copper/Zinc Diagnostic Panel
Adeona Pharmaceuticals, Inc. (AMEX: AEN), a specialty pharmaceutical company dedicated to the awareness, diagnosis, prevention and treatment of zinc deficiency and chronic copper toxicity in the mature population, today announced the initial formation of its sales and marketing team and pre-launch efforts for its CopperProof serum-based copper/zinc diagnostic panel, which will be offered through Adeona's Hartlab subsidary. The CopperProof panel is a diagnostic test panel intended to provide a comprehensive look at the metabolic serum copper and zinc status of patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI). Defects in copper metabolism and high free copper levels are increasingly being recognized as significant factors in the progression of neurodegenerative diseases, including AD and MCI. A clinical zinc deficiency in AD patients has also been recognized for the first time in a recent Adeona-sponsored clinical study.
In preparation for the near term launch of its Copperproof diagnostic panel, Adeona has begun hiring a sales and marketing team for key markets. These initial efforts are intended to target neurologists, psychiatrists, gerontologists, nursing homes and other physicians and institutions that regularly treat patients with AD and MCI. Adeona intends to continue to build a small specialty sales force of individuals each having extensive experience calling upon these specialty practices.
On July 9, 2009 Adeona completed the acquisition of Hartlab LLC a CLIA-certified clinical reference laboratory located in
Max Lyon, Adeona's CEO, stated, "This is a milestone for Adeona. It is our intention to continue to grow the sales and marketing team with individuals having substantial experience in the AD and MCI markets. We consider chronic copper toxicity to be a significantly under-recognized and modifiable risk factor for the progression of AD and MCI. We have also recently completed the first international epidemiological study finding a correlation between copper plumbing tube use and the rates of prevalence of Alzheimer's disease by country and believe that such study lends further support to the growing body of evidence that chronic inorganic copper exposure plays an important role in the progression of Alzheimer's disease. Using Adeona's proprietary, modified oral zinc delivery technologies, Adeona is preparing to initiate the first clinical trial of oral zinc therapy for the once-a-day dietary management of AD and MCI."
TFN, THE FOOTBALL NETWORK (OTC: TFNK)
"Up 56.25% on Tuesday"
Detailed Quote: http://www.otcpicks.com/quotes/TFNK.php
The Football Network (TFN) specializes in coverage of football. TFN produces a radio show, "TFN's Football Focus", which is carried on radio stations nationwide. The company is developing a 24-hour cable television channel devoted exclusively to football, providing coverage of the sport, its players, behind the scenes reports, and shows devoted to football-related topics. It has offices in Marina Del Rey,
TFNK News:
August 25 - TFN, The Football Network, Inc. Announces Plans for Second Sports Website
TFN, The Football Network, Inc. (OTC: TFNK) has signed an agreement to produce the second in a series of websites aimed at the sports market and sports fans. "We will be creating a second website named, 'TFN, The Fan's Network, Soccer'," said Jantonio Turner, President. "The new website will feature highlights and clips of soccer based programming and will be ready in 30 days."
"It is our intention to become a destination spot for all fans of all of the major sports and we will be developing the content and traffic for the major sports in the months to come," added Turner. "While we still have a long way to go, this is just another step in the continuation of the plan we previously announced and I am pleased with our progress," concluded Turner.
SOFTNET TECHNOLOGY CORPORATION (OTCBB: SOFN)
"Up 91.67% on Tuesday"
Detailed Quote: http://www.otcpicks.com/quotes/SOFN.php
SoftNet Technology Corp. is a Professional Services company offering professional expertise to enterprise and service provider clients. SoftNet's services are organized in three practice specialties, including Infrastructure Services, Application Development and Government Services.
SOFN News:
January 21 - SoftNet Technology Selected as Preferred Provider by National Telco
SoftNet Technology Corp. (OTCBB: SOFN) (German WKN: TG6) announced that it has been selected as a Preferred Provider for a National Wireless Telecommunications provider.
SoftNet management participated in a rigorous RFP process by the company of which the pool of providers was limited to approximately one in four of the organizations seeking status of Preferred Provider by this carrier. The reduction in the number of authorized providers will add value to our relationship with the client and the Company's overall business plan. Prior to the RFP, SoftNet was competing with numerous like firms. With the selection of fewer firms in the RFP process SoftNet will be one of a few select companies submitting against numerous projects and engagements this client relies on from outside Professional Services firms. The selection of SoftNet was based on a number of factors, including the Company's long term standing with the carrier, the reputation for supplying quality candidates for engagements, the competitive pricing structure SoftNet is able to achieve and the attention to the account by SoftNet Management.
“The management team of SoftNet is proud of this selection. It speaks to the focus the Company places on client satisfaction, the quality of work performed and the relationship of managers with their peers at a customer organization. The benefit of this status is that it could result in an increase in engagements for SoftNet in our core businesses, infrastructure and application development through a more efficient, timely and personalized approached to securing engagements. This will allow the Company to showcase and leverage two of our key reputation drivers; the quality of our consultants and recruiting capability,” said Jim Booth, President of SoftNet.
OTCPicks.com is located at
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stockbroker before investing.
Information contained in our report will contain "forward looking statements" as defined under
Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward-looking statements. These forward-looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward-looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.
Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.
